Table 3.
Interleukin levels according to the sex.
n | Male | n | Female | p | |
---|---|---|---|---|---|
Mean ± SD | Mean ± SD | ||||
Median (Q1–Q3) | Median (Q1–Q3) | ||||
Control Group | |||||
IL-2 | 15 | 297 ± 137 | 15 | 319 ± 166 | 0.724 |
292.72 (189–361.58) | 284 (224.42–327.89) | ||||
IL-4 | 15 | 201 ± 133 | 15 | 166 ± 82 | 0.663 |
149.30 (99.17–254.26) | 150.86 (87.64–251.26) | ||||
IL-15 | 15 | 225 ± 244 | 15 | 110 ± 60 | 0.178 |
151.39 (80.31–294.1) | 118.69 (48–144.1) | ||||
IL-17 | 15 | 101 ± 52 | 15 | 117 ± 83 | 0.820 |
73.54 (61.04–170.59) | 99.81 (45.08–202.42) | ||||
Patient Group | |||||
IL-2 | 30 | 742 ± 662 | 31 | 678 ± 831 | 0.260 |
378.24 (314.86–911.03) | 348.47 (290.95–462.66) | ||||
IL-4 | 30 | 605 ± 463 | 31 | 486 ± 413 | 0.337 |
344.15 (276.71–1146.33) | 303.53 (262.56–536.01) | ||||
IL-15 | 30 | 504 ± 631 | 31 | 467 ± 651 | 0.937 |
193.78 (130.28–590.95) | 200.42 (139.63–446.04) | ||||
IL-17 | 30 | 148 ± 152 | 31 | 168 ± 222 | 0.920 |
85.03 (57.33–192.49) | 78.97 (62.49–124.5) |
IL, Interleukin; SD, Standard Deviation.